References
- Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, de Prost D. (2003). Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23:e61–e64.
- Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, Fedi S, Lapini I, Rostagno C, Comeglio M, Brogi D, Gensini G, Abbate R. (2004). Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 147:516–521.
- Grove EL, Ørntoft TF, Lassen JF, Jensen HK, Kristensen SD. (2004). The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med 255:637–644.
- Hansson GK, Libby P, Schönbeck U, Yan ZQ. (2002). Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91:281–291.
- Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D’Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB; IGIGI Investigators. (2005). Polymorphisms of the interleukin-1β gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25:222–227.
- Incalcaterra E, Hoffmann E, Averna MR, Caimi G. (2004). Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol 52:287–312.
- Libby P. (2001). Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365–372.
- Licastro F, Chiappelli M, Caldarera CM, Tampieri C, Nanni S, Gallina M, Branzi A. (2004). The concomitant presence of polymorphic alleles of interleukin-1β, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 125:575–579.
- Meier P, Antonov J, Zbinden R, Kuhn A, Zbinden S, Gloekler S, Delorenzi M, Jaggi R, Seiler C. (2009). Non-invasive gene-expression-based detection of well-developed collateral function in individuals with and without coronary artery disease. Heart 95:900–908.
- Morgan TM, Krumholz HM, Lifton RP, Spertus JA. (2007). Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297:1551–1561.
- Muckian C, Fitzgerald A, O’Neill A, O’Byrne A, Fitzgerald DJ, Shields DC. (2002). Genetic variability in the extracellular matrix as a determinant of cardiovascular risk: association of type III collagen COL3A1 polymorphisms with coronary artery disease. Blood 100:1220–1223.
- Nojiri T, Morita H, Imai Y, Maemura K, Ohno M, Ogasawara K, Aizawa T, Saito A, Hayashi D, Hirata Y, Sugiyama T, Yamazaki T, Nagai R. (2003). Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 92:181–186.
- Ott I, Koch W, von Beckerath N, de Waha R, Malawaniec A, Mehilli J, Schömig A, Kastrati A. (2004). Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction. Atherosclerosis 177:189–191.
- Panahloo A, Mohamed-Ali V, Gray RP, Humphries SE, Yudkin JS. (2003). Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene. Atherosclerosis 9:333–336.
- Ross R. (1981). Atherosclerosis: a question of endothelial integrity and growth control of smooth muscle. Harvey Lect 77:161–182.
- Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ. (2004). Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J 25:459–467.
- von Bary C, Makowski M, Preissel A, Keithahn A, Warley A, Spuentrup E, Buecker A, Lazewatsky J, Cesati R, Onthank D, Schickl N, Schachoff S, Hausleiter J, Schömig A, Schwaiger M, Robinson S, Botnar R. (2011). MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circ Cardiovasc Imaging 4:147–155.
- Weissber PL, Rudd JHF. (2002). Atherosclerotic biology and epidemiologyof disease. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott and Williams & Wilkins, 3–14.
- Weissberg PL, Clesham GJ, Bennett MR. (1996). Is vascular smooth muscle cell proliferation beneficial? Lancet 347:305–307.
- Ye S, Gale CR, Martyn CN. (2003). Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J 24:1668–1671.